NeuroPet

Company Overview

Snapshot

Founded in November 2019 by David Ben Ha'rosh, Prof. Nathan Intrator, Sharon Ronen, Ronen Golan, and Prof. Simon Lytsin, NeuroPet operated with 1–10 employees. The company ceased operations in January 2022.

Business overview

NeuroPet developed a brain-machine interface activity system for animals, designed to provide real-time insights into their thoughts and feelings. The core technology utilized proprietary real-time algorithms, deep artificial intelligence, and machine learning, accessible via web interfaces, mobile devices, or voice text. The system, relying on a single EEG channel, produced unique brain activity biomarkers through advanced mathematical signal processing and sensitive electronics. NeuroPet focused on verticals such as pet owners and health and remote care, with potential applications in medical research for drug development and monitoring effects over time. The company aimed to help detect pain, neurodegenerative diseases, mood disorders, and even basic needs in pets, operating within the Digital Health and Medical Technologies sector.

Company Intelligence Q&A

What is NeuroPet's primary focus?

NeuroPet focuses on developing a brain-machine interface system to monitor pets' emotions and behavior in real time, aiming to enhance human understanding of animal needs.

When was NeuroPet founded?

NeuroPet was founded in November 2019.

What technology does NeuroPet utilize?

NeuroPet utilizes proprietary real-time algorithms, deep artificial intelligence, and machine learning, along with advanced mathematical signal processing and sensitive electronics, to analyze brain activity.

What markets does NeuroPet serve?

NeuroPet serves pet owners and the health and remote care sectors, with potential applications in medical research for drug development.

When did NeuroPet cease operations?

NeuroPet ceased to operate in January 2022.